Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of -2671.72% is in line with its 4-year average of -2487.71%, near the high end of its 4-year range (-10328.89%–-48.20%).
263.94% below its 12-month average of -734.11%.
Reported quarterly EBITDA margin; no daily interpolation. Q3 FY2024 (2024-09-30): -48.20%.
EBITDA MARGIN
-2671.72%
EBITDA MARGIN AVG TTM
-734.11%
EBITDA MARGIN AVG 3Y
-2020.14%
EBITDA MARGIN AVG 5Y
N/A
EBITDA MARGIN AVG 10Y
N/A
EBITDA MARGIN AVG 15Y
N/A
EBITDA MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-263.94%
CURRENT VS 3Y AVG
-32.25%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
BeyondSpring Inc.
Market Cap
$32.32M
EBITDA Margin
-2671.72%
TTM Avg
-734.11%
3Y Avg
-2020.14%
5Y Avg
N/A
Market Cap
$32.31M
EBITDA Margin
-29.82%
TTM Avg
-228.84%
3Y Avg
-176.67%
5Y Avg
-120.12%
Market Cap
$31.36M
EBITDA Margin
-108.41%
TTM Avg
-31.49%
3Y Avg
5.24%
5Y Avg
21.14%
Market Cap
$33.42M
EBITDA Margin
-3982.39%
TTM Avg
-3087.93%
3Y Avg
-1849.71%
5Y Avg
-2051.20%
Market Cap
$33.52M
EBITDA Margin
-7905.63%
TTM Avg
-7905.63%
3Y Avg
-7905.63%
5Y Avg
-7905.63%
Market Cap
$30.65M
EBITDA Margin
-10097.04%
TTM Avg
-6618.17%
3Y Avg
-8743.58%
5Y Avg
-8072.84%
Market Cap
$35.89M
EBITDA Margin
-6.58%
TTM Avg
-1.77%
3Y Avg
-0.14%
5Y Avg
1.64%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| BeyondSpring Inc. (BYSI) | $32.32M | -2671.72% | -734.11% | -2020.14% | N/A |
| EUDA Health Holdings Limited (EUDA)vs › | $32.31M | -29.82% | -228.84% | -176.67% | -120.12% |
| Baird Medical Investment Holdings Limited (BDMD)vs › | $31.36M | -108.41% | -31.49% | 5.24% | 21.14% |
| Aligos Therapeutics, Inc. (ALGS)vs › | $33.42M | -3982.39% | -3087.93% | -1849.71% | -2051.20% |
| Grace Therapeutics, Inc. (GRCE)vs › | $33.52M | -7905.63% | -7905.63% | -7905.63% | -7905.63% |
| Context Therapeutics Inc. (CNTX)vs › | $30.92M | N/A | N/A | N/A | N/A |
| CervoMed Inc. (CRVO)vs › | $30.65M | -10097.04% | -6618.17% | -8743.58% | -8072.84% |
| Accuray Incorporated (ARAY)vs › | $35.89M | -6.58% | -1.77% | -0.14% | 1.64% |
| DocGo Inc. (DCGO)vs › | $36.05M | -22.81% | -7.79% | -0.80% | -0.97% |
| aTyr Pharma, Inc. (ATYR)vs › | $28.43M | -40038.95% | -34141.60% | -20873.74% | -16727.01% |
Gross Margin
0.0%
EBITDA Margin
-2671.7%
Operating Margin
0.0%
Net Margin
0.0%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2024-09-30 | -48.20% |
| 2024-06-30 | -727.10% |
| 2024-03-31 | -727.10% |
| 2023-12-31 | -1082.08% |
| 2023-09-30 | -1086.07% |
| 2023-06-30 | -1527.77% |
| 2023-03-31 | -1527.77% |
| 2022-12-31 | -2417.04% |
| 2022-09-30 | -2429.70% |
| 2022-06-30 | -3073.59% |
| 2022-03-31 | -3073.59% |
| 2021-12-31 | -3102.07% |
| 2021-09-30 | -5439.76% |
| 2021-06-30 | -5905.03% |
| 2021-03-31 | -5148.82% |
| 2020-12-31 | -10328.89% |
